STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR
Provided are a stable secukinumab injection and a preparation method therefor. The stable secukinumab injection is composed of the following ingredients: 50 mg/ml - 300 mg/ml of secukinumab, 5 mmol/L - 50 mmol/L of histidine and a histidine hydrochloride, 5 mmol/L - 50 mmol/L of methionine, 150 mmol...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WEI, Shanshan ZHANG, Zhongyu FAN, Xindan CHANG, Xiaohui WANG, Depeng LENG, Chunsheng ZHANG, Nan |
description | Provided are a stable secukinumab injection and a preparation method therefor. The stable secukinumab injection is composed of the following ingredients: 50 mg/ml - 300 mg/ml of secukinumab, 5 mmol/L - 50 mmol/L of histidine and a histidine hydrochloride, 5 mmol/L - 50 mmol/L of methionine, 150 mmol/L - 400 mmol/L of a low-sugar alcohol, and 0.01 % - 0.02% of polysorbate 80, wherein the balance is water for injection, and the pH is 5.0 - 7.0. Stability tests prove that the quality of the stable secukinumab injection is stable, wherein the stability thereof is superior to that of commercial varieties on the market, and same has various indicators that meet the relevant regulations of the Chinese Pharmacopoeia, and has good application prospects. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3970744B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3970744B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3970744B13</originalsourceid><addsrcrecordid>eNrjZLAJDnF08nFVCHZ1DvX29Av1dXRS8PTzcnUO8fT3U3D0c1EICHINcAxyBPN9XUM8_F0UQjxcg1zd_IN4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxpbmBuYmJk6ExEUoAxqkpXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR</title><source>esp@cenet</source><creator>WEI, Shanshan ; ZHANG, Zhongyu ; FAN, Xindan ; CHANG, Xiaohui ; WANG, Depeng ; LENG, Chunsheng ; ZHANG, Nan</creator><creatorcontrib>WEI, Shanshan ; ZHANG, Zhongyu ; FAN, Xindan ; CHANG, Xiaohui ; WANG, Depeng ; LENG, Chunsheng ; ZHANG, Nan</creatorcontrib><description>Provided are a stable secukinumab injection and a preparation method therefor. The stable secukinumab injection is composed of the following ingredients: 50 mg/ml - 300 mg/ml of secukinumab, 5 mmol/L - 50 mmol/L of histidine and a histidine hydrochloride, 5 mmol/L - 50 mmol/L of methionine, 150 mmol/L - 400 mmol/L of a low-sugar alcohol, and 0.01 % - 0.02% of polysorbate 80, wherein the balance is water for injection, and the pH is 5.0 - 7.0. Stability tests prove that the quality of the stable secukinumab injection is stable, wherein the stability thereof is superior to that of commercial varieties on the market, and same has various indicators that meet the relevant regulations of the Chinese Pharmacopoeia, and has good application prospects.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240814&DB=EPODOC&CC=EP&NR=3970744B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240814&DB=EPODOC&CC=EP&NR=3970744B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEI, Shanshan</creatorcontrib><creatorcontrib>ZHANG, Zhongyu</creatorcontrib><creatorcontrib>FAN, Xindan</creatorcontrib><creatorcontrib>CHANG, Xiaohui</creatorcontrib><creatorcontrib>WANG, Depeng</creatorcontrib><creatorcontrib>LENG, Chunsheng</creatorcontrib><creatorcontrib>ZHANG, Nan</creatorcontrib><title>STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR</title><description>Provided are a stable secukinumab injection and a preparation method therefor. The stable secukinumab injection is composed of the following ingredients: 50 mg/ml - 300 mg/ml of secukinumab, 5 mmol/L - 50 mmol/L of histidine and a histidine hydrochloride, 5 mmol/L - 50 mmol/L of methionine, 150 mmol/L - 400 mmol/L of a low-sugar alcohol, and 0.01 % - 0.02% of polysorbate 80, wherein the balance is water for injection, and the pH is 5.0 - 7.0. Stability tests prove that the quality of the stable secukinumab injection is stable, wherein the stability thereof is superior to that of commercial varieties on the market, and same has various indicators that meet the relevant regulations of the Chinese Pharmacopoeia, and has good application prospects.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJDnF08nFVCHZ1DvX29Av1dXRS8PTzcnUO8fT3U3D0c1EICHINcAxyBPN9XUM8_F0UQjxcg1zd_IN4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxpbmBuYmJk6ExEUoAxqkpXg</recordid><startdate>20240814</startdate><enddate>20240814</enddate><creator>WEI, Shanshan</creator><creator>ZHANG, Zhongyu</creator><creator>FAN, Xindan</creator><creator>CHANG, Xiaohui</creator><creator>WANG, Depeng</creator><creator>LENG, Chunsheng</creator><creator>ZHANG, Nan</creator><scope>EVB</scope></search><sort><creationdate>20240814</creationdate><title>STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR</title><author>WEI, Shanshan ; ZHANG, Zhongyu ; FAN, Xindan ; CHANG, Xiaohui ; WANG, Depeng ; LENG, Chunsheng ; ZHANG, Nan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3970744B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WEI, Shanshan</creatorcontrib><creatorcontrib>ZHANG, Zhongyu</creatorcontrib><creatorcontrib>FAN, Xindan</creatorcontrib><creatorcontrib>CHANG, Xiaohui</creatorcontrib><creatorcontrib>WANG, Depeng</creatorcontrib><creatorcontrib>LENG, Chunsheng</creatorcontrib><creatorcontrib>ZHANG, Nan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEI, Shanshan</au><au>ZHANG, Zhongyu</au><au>FAN, Xindan</au><au>CHANG, Xiaohui</au><au>WANG, Depeng</au><au>LENG, Chunsheng</au><au>ZHANG, Nan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR</title><date>2024-08-14</date><risdate>2024</risdate><abstract>Provided are a stable secukinumab injection and a preparation method therefor. The stable secukinumab injection is composed of the following ingredients: 50 mg/ml - 300 mg/ml of secukinumab, 5 mmol/L - 50 mmol/L of histidine and a histidine hydrochloride, 5 mmol/L - 50 mmol/L of methionine, 150 mmol/L - 400 mmol/L of a low-sugar alcohol, and 0.01 % - 0.02% of polysorbate 80, wherein the balance is water for injection, and the pH is 5.0 - 7.0. Stability tests prove that the quality of the stable secukinumab injection is stable, wherein the stability thereof is superior to that of commercial varieties on the market, and same has various indicators that meet the relevant regulations of the Chinese Pharmacopoeia, and has good application prospects.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP3970744B1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | STABLE SECUKINUMAB INJECTION AND PREPARATION METHOD THEREFOR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A04%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEI,%20Shanshan&rft.date=2024-08-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3970744B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |